Abbott Laboratories (ABT)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 18,706,000 | 17,975,000 | 19,142,000 | 18,537,000 | 15,003,000 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $18,706,000K ÷ $—K
= —
The payables turnover ratio for Abbott Laboratories for the years 2020 to 2024 is not available in the provided data. The payables turnover ratio indicates how efficiently a company is managing its outstanding supplier payments. A higher turnover ratio generally suggests that the company is paying its suppliers more quickly.
Without the specific payables turnover values for Abbott Laboratories, it is challenging to assess how effectively the company is managing its accounts payable. Further financial information or historical data would be required to analyze any trends or issues related to Abbott Laboratories' payables turnover over the specified period.
Peer comparison
Dec 31, 2024